Twist Bioscience Corp Quarterly Operating Income (Loss) in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Twist Bioscience Corp quarterly/annual Operating Income (Loss) history and growth rate from Q4 2017 to Q3 2024.
  • Twist Bioscience Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$36M, a 28.1% increase year-over-year.
  • Twist Bioscience Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$221M, a 1.69% decline year-over-year.
  • Twist Bioscience Corp annual Operating Income (Loss) for 2024 was -$221M, a 1.69% decline from 2023.
  • Twist Bioscience Corp annual Operating Income (Loss) for 2023 was -$217M, a 7.5% increase from 2022.
  • Twist Bioscience Corp annual Operating Income (Loss) for 2022 was -$235M, a 53.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$221M -$36M +$14.1M +28.1% Jul 1, 2024 Sep 30, 2024 10-K 2024-11-18
Q2 2024 -$235M -$88.9M -$28.1M -46.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 -$207M -$48.9M +$12.7M +20.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$220M -$47M -$2.35M -5.26% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-02
Q3 2023 -$217M -$50.1M +$6.76M +11.9% Jul 1, 2023 Sep 30, 2023 10-K 2024-11-18
Q2 2023 -$224M -$60.8M +$382K +0.63% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 -$224M -$61.6M -$835K -1.37% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$223M -$44.6M +$11.3M +20.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-02
Q3 2022 -$235M -$56.9M -$17.1M -42.9% Jul 1, 2022 Sep 30, 2022 10-K 2024-11-18
Q2 2022 -$218M -$61.2M -$19M -45.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$199M -$60.8M -$22.8M -60% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$176M -$55.9M -$23.1M -70.6% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 -$153M -$39.8M -$15.8M -66.1% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-21
Q2 2021 -$137M -$42.1M -$13.9M -49.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$123M -$38M -$5.92M -18.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$117M -$32.8M +$23M +41.3% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 -$140M -$24M +$7.6M +24.1% Jul 1, 2020 Sep 30, 2020 10-K/A 2023-06-05
Q2 2020 -$148M -$28.2M -$75K -0.27% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$148M -$32.1M -$5.82M -22.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$142M -$55.8M -$32.9M -144% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 -$109M -$31.6M -$11.9M -60.2% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-23
Q2 2019 -$97M -$28.1M -$10.6M -60.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$86.4M -$26.3M -$9.65M -58% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$76.7M -$22.9M -$6.15M -36.7% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 -$70.6M -$19.7M Jul 1, 2018 Sep 30, 2018 10-K 2020-11-27
Q2 2018 -$17.5M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$16.6M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$16.8M Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.